14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Dec 06, 2018 $9.83 $10.08 $9.03 $10.01 995 340
Dec 04, 2018 $11.00 $11.01 $10.09 $10.14 629 834
Dec 03, 2018 $10.50 $11.42 $10.34 $11.07 575 495
Nov 30, 2018 $9.94 $10.33 $9.81 $10.24 299 023
Nov 29, 2018 $10.26 $10.38 $9.92 $9.95 327 422
Nov 28, 2018 $10.14 $10.29 $9.71 $10.29 481 357
Nov 27, 2018 $10.84 $10.92 $10.05 $10.12 408 887
Nov 26, 2018 $10.37 $11.00 $10.30 $10.97 368 230
Nov 23, 2018 $10.41 $10.76 $10.16 $10.26 247 990
Nov 21, 2018 $10.03 $10.62 $9.89 $10.51 400 757
Nov 20, 2018 $9.85 $10.21 $9.69 $9.88 646 172
Nov 19, 2018 $10.64 $10.75 $9.96 $10.07 643 306
Nov 16, 2018 $10.84 $11.00 $10.43 $10.82 696 563
Nov 15, 2018 $10.74 $11.23 $10.74 $10.84 377 196
Nov 14, 2018 $11.63 $11.94 $10.59 $10.86 697 934
Nov 13, 2018 $11.69 $12.25 $11.15 $11.52 1 183 408
Nov 12, 2018 $11.84 $12.10 $11.44 $11.46 343 829
Nov 09, 2018 $13.25 $13.25 $11.76 $11.90 676 233
Nov 08, 2018 $13.05 $13.29 $12.75 $13.00 989 838
Nov 07, 2018 $12.18 $13.15 $11.83 $13.06 1 086 340
Nov 06, 2018 $11.22 $12.63 $10.93 $12.00 1 409 905
Nov 05, 2018 $12.00 $12.08 $10.58 $10.99 2 638 198
Nov 02, 2018 $16.26 $16.80 $11.70 $11.89 4 205 200
Nov 01, 2018 $16.68 $17.59 $16.52 $16.97 682 915
Oct 31, 2018 $16.00 $16.80 $15.82 $16.55 432 664
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT